Market research
000153.SHE Anhui Fengyuan Pharmaceutical Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 3B
- P/E ratio
- 28.9
- Analyst target
- Not available
- Dividend yield
- 1.6%
- Beta
- 0.34
Community
Investor discussion
1 comment
Sign in to join the 000153.SHE discussion.
5 years, 5 months ago
Anhui Fengyuan Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 16.0% above its 200 day moving average.
From a valuation standpoint, the stock is 92.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Anhui Fengyuan Pharmaceutical Co., Ltd's total revenue rose by 3.8% to $849M since the same quarter in the previous year.
Its net income has dropped by 30.6% to $13M since the same quarter in the previous year.
Finally, its free cash flow fell by 791.8% to $-21M since the same quarter in the previous year.
Based on the above factors, Anhui Fengyuan Pharmaceutical Co., Ltd gets an overall score of 3/5.